Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialBruce Cree, Piotr Sokolowski, Gary Cutter et al.|The Lancet Neurology|2020Cited by 104
Oligoclonal bands predict multiple sclerosis in children with optic neuritisNicole Heußinger, Mathias Buttmann, Peter Hofstetter et al.|Annals of Neurology|2015Cited by 76
Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier BreakdownAxel Haarmann, Mathias Buttmann|International Journal of Molecular Sciences|2019Cited by 38